Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-01 Sale |
2024-08-05 4:52 pm |
Cerevel Therapeutics Holdings Inc. | CERE | BAIN CAPITAL INVESTORS LLC BC Perception Holdings LP BCPE Perception GP LLC Bain Capital Fund XII LP Bain Capital Partners XII LLC Director 10% Owner |
65,679,781 | $0 | $0 | 0 (Indirect) |
View |
| 2024-08-01 Sale |
2024-08-05 4:51 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
65,693,524 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:49 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
65,693,524 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:38 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sanchez Ramiro Chief Medical Officer |
14,673 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:36 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director |
13,743 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:36 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renaud Ronald C JR President & CEO |
244,309 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:34 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director |
13,743 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:34 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Akamine Scott Chief Legal Officer |
7,527 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:32 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
58,876 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:30 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
6,370 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:30 pm |
Cerevel Therapeutics Holdings Inc. | CERE | DiPietro Kenneth Chief Human Resources Officer |
25,042 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:29 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Tregoning Kathleen See Remarks |
10,666 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:28 pm |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
444,609 | $0 | $0 | 0 (Indirect Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:26 pm |
Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer |
16,913 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
56,553 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:24 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Bodenrader Mark See Remarks |
17,724 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:21 pm |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
13,743 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:20 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
25,928 | $0 | $0 | 0 (Direct) |
View |
| 2024-08-01 Sale |
2024-08-05 4:20 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Burgess Paul D. See Remarks |
45,727 | $0 | $0 | 0 (Direct) |
View |
| 2024-07-01 Sale |
2024-07-03 4:05 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
25,000 | $41.18 | $1,029,535 | 2,203,345 (Direct) |
View |
| 2024-06-03 Sale |
2024-06-05 4:05 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $40.61 | $2,030,520 | 2,218,055 (Direct) |
View |
| 2024-05-10 Sale |
2024-05-14 5:16 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $42.1 | $2,105,125 | 2,268,055 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-03 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $42.33 | $2,116,640 | 2,318,055 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:15 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $41.01 | $2,050,550 | 2,368,055 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-04 5:49 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $41.16 | $2,057,890 | 2,418,055 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 7:19 pm |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
2,161 | $41.54 | $89,777 | 21,431 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-08 7:14 pm |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
2,506 | $41.54 | $104,110 | 61,960 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-08-01 Equity Swap |
2024-08-05 6:25 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PFIZER INC Former 10% Owner |
27,349,211 | $45 | 0 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 4:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
25,000 | $3.5 | 2,203,345 (Direct) |
View |
| 2024-07-01 Exercise |
2024-07-03 4:05 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
25,000 | $0 | 2,203,345 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:22 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Gordon Christopher R Director 10% Owner |
10,461 | $0 | 65,693,524 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 5:12 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Koppel Adam Director 10% Owner |
10,461 | $0 | 65,693,524 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:34 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
10,290 | $0 | 25,928 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:34 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | DEKKERS MARIJN E Director |
10,461 | $0 | 444,609 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:34 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PATRICK DEVAL L Director |
10,461 | $0 | 13,743 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | RIEDEL NORBERT G Director |
10,461 | $0 | 56,553 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:30 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Giordano Douglas E. Director |
10,461 | $0 | 13,743 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:28 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
10,461 | $0 | 58,876 (Direct) |
View |
| 2024-06-05 Option Award |
2024-06-07 4:27 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Mckernan Ruth Director |
10,461 | $0 | 13,743 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-05 4:05 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $3.5 | 2,218,055 (Direct) |
View |
| 2024-06-03 Exercise |
2024-06-05 4:05 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $0 | 2,218,055 (Direct) |
View |
| 2024-05-10 Exercise |
2024-05-14 5:16 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $3.5 | 2,268,055 (Direct) |
View |
| 2024-05-10 Exercise |
2024-05-14 5:16 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $0 | 2,268,055 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $3.5 | 2,318,055 (Direct) |
View |
| 2024-04-01 Exercise |
2024-04-03 4:15 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $0 | 2,318,055 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 4:15 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $3.5 | 2,368,055 (Direct) |
View |
| 2024-03-04 Exercise |
2024-03-06 4:15 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $0 | 2,368,055 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-04 5:49 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $3.5 | 2,418,055 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-04 5:49 pm |
N/A 2028-12-24 |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
50,000 | $0 | 2,418,055 (Direct) |
View |
| 2024-02-20 Gift |
2024-02-21 4:54 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director |
170,317 | $0 | 10,794,876 (Indirect) |
View |
| 2023-08-29 Ownership |
2024-02-13 4:16 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Sulzberger Gabrielle Director |
562 | $0 | 48,415 (Direct) |
View |
| 2024-02-06 Exercise |
2024-02-08 7:19 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | Renger John Chief Scientific Officer |
5,020 | $0 | 21,431 (Direct) |
View |
| 2024-02-06 Exercise |
2024-02-08 7:14 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | COLES N ANTHONY Director |
15,440 | $0 | 61,960 (Direct) |
View |
| 2024-01-19 Option Award |
2024-01-23 5:51 pm |
N/A N/A |
Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer |
81,065 | $0 | 81,065 (Direct) |
View |